Latest update December 13th, 2024 1:00 AM
Jul 11, 2010 News
– sister Pharmaceutical companies likely to bid at same time
The Ministry of Health (MOH) has been over time been slammed for its method of procuring drugs through a sole agency, the New Guyana Pharmaceutical Corporation. The current procurement method is by selective tendering, which a Cabinet decision in 2008 allowed, by consenting to a waiver of the Tender Board conditions.
It has recently been disclosed, however, that there are new procedures in the making. The MOH is embarking on a new method of acquiring drugs.
For this year, the Tender Board granted its approval for the purchase drugs from the pre-qualified list of suppliers. This permission expired at the end of June. The MOH is now in the process of preparing a tender document that will be put in the public domain, for all suppliers to indicate their interest in supplying drugs to the Ministry.
That document is now in draft stage, and once completed, will be sent to the Tender Board for approval.
Once approved, it will be used as the basis for pre-qualification of suppliers to supply the Ministry with drugs. It is hoped that this document will be ready before the end of this month.
It has been noted that there are two sister pharmaceutical companies, owned by Queens Atlantic Investments, that will be bidding: The New Guyana Pharmaceutical Corporation and sister company Health Care International, which is set to begin business in a few months time.
Dec 13, 2024
SportsMax – On the back of a magnificent debut century by Amir Jangoo, the West Indies completed a 3-0 ODI series sweep over Bangladesh with a four-wicket triumph in the third game at Warner...Peeping Tom… Kaieteur News- There’s an old saying in Guyana: “You can’t put a little boy to do a big man’s... more
By Sir Ronald Sanders Kaieteur News- The election of a new Secretary General of the Organization of American States (OAS),... more
Freedom of speech is our core value at Kaieteur News. If the letter/e-mail you sent was not published, and you believe that its contents were not libellous, let us know, please contact us by phone or email.
Feel free to send us your comments and/or criticisms.
Contact: 624-6456; 225-8452; 225-8458; 225-8463; 225-8465; 225-8473 or 225-8491.
Or by Email: [email protected] / [email protected]